Completed
A Bioequivalence Study Of 4 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects
NCT00902187
- Conditions
- Treatment of Overactive Bladder
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States